Scientists test CRISPR gene editing on 2 U.S. cancer patients

Gene-editing.
(Image credit: vhcal/ iStock)

CRISPR, a new technique for editing DNA, is being tested in clinical trials for the first time in the U.S., NPR reported on Tuesday.

After a few studies based in China on using the gene-editing technology to treat disease, two American cancer patients are being treated with CRISPR for their cancer. The patients, being treated as part of a study at the University of Pennsylvania, had both "relapsed after undergoing standard treatment." One patient was diagnosed with multiple myeloma, a form of cancer that affects plasma cells in the blood; the other was diagnosed with sarcoma, a tumor that affects connective tissue in the body.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us

Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.